BRCA2 mutation carriers homozygous for the 72Pro allele had an older mean age of diagnosis of breast cancer compared with breast cancer cases homozygous for the 72Arg allele and heterozygous carriers of this TP53 polymorphism, but overall the difference was not statistically significant. This evidence concerns the gene TP53 and breast carcinoma.